Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: A pilot study

Journal of Photochemistry and Photobiology B: Biology

Volumn 91, Issue 1, 2008, Pages 41-50

  Dragicevic Curic, Nina ^a   Gräfe, Susanna ^b   Albrecht, Volker ^b   Fahr, Alfred ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Biolitec AG   (Germany)

Author keywords

Invasomes; Liposomes; Photodynamic therapy; Temoporfin

Indexed keywords

ALCOHOL; CINEOLE; CITRAL; LIMONENE; LIPOSOME; PENETRATION ENHANCING AGENT; TEMOPORFIN; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HT29; CELL VACUOLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYDROPHOBICITY; ILLUMINATION; MOUSE; MOUTH CARCINOMA; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PILOT STUDY; PRIORITY JOURNAL; RECURRENT CANCER; SKIN ABSORPTION; SKIN CANCER; SUBCUTANEOUS TISSUE TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; TUMOR VOLUME;

ADMINISTRATION, TOPICAL; ANIMALS; CELL LINE, TUMOR; ETHANOL; FEMALE; HUMANS; LIPOSOMES; MESOPORPHYRINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; SKIN NEOPLASMS; TERPENES; TUMOR BURDEN;

MUS;

EID: 41849092684     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2008.01.009     Document Type: Article

References (43)

1. Bonnet R. Photodynamic therapy in historical perspectives. Rev. Contemp. Pharmacotherap. 10 (1999) 1-17
2. Okunara T., and Kato H. Potential applications of photodynamic therapy. Rev. Contemp. Pharmacotherap. 10 (1999) 59-68
3. Fritsch C., Lang K., Neuse W., Ruzicka T., and Lehmann P. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol. Appl. Skin Physiol. 11 (1998) 358-373
4. Kurwa H.A., Yong-Gee S.A., Seed P.T., Markey A.C., and Barlow R.J. Randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J. Am. Acad. Dermatol. 41 (1999) 414-418
5. Morton C.A. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?. J. Dermatolog. Treat. 13 Suppl 1 (2002) S25-S29
6. Kübler A.C. Photodynamic therapy. Med. Laser Appl. 20 (2005) 37-45
7. Biel M.A. Photodynamic therapy in head and neck cancer. Curr. Oncol. Rep. 4 (2002) 87-96
8. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 1 (2000) 212-219
9. Ris H.-B., Altermatt J.H., Stewart C.M., Schaffner T., Wang Q., Lim C.K., Bonnett R., and Althaus U. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index. Int. J. Cancer 55 (1993) 245-249
10. Kübler A.C., Haase T., and Staff C. Photodynamic therapy of primary non-melanomatous skin tumors of the head and neck. Laser Surg. Med. 25 (1999) 60-68
11. Lopez R.F., Bentley M.V., Begona Delgado-Charro M., and Guy R.H. Optimization of aminolevulinic acid delivery by iontophoresis. J. Cont. Release 88 (2003) 65-70
12. Wang S., Kara M., and Krishnan T.R. Transdermal delivery of cyclosporine: a using electroporation. J. Cont. Release 50 (1998) 61-70
13. Cancel L.M., Tarbell J.M., and Ben-Jebria A. Fluorescein permeability and electrical resistance of human skin during low frequency ultrasound application. J. Pharm. Pharmacol. 56 (2004) 1109-1118
14. Liu H., Li S., Wang Y., Yao H., and Zhang Y. Effect of vehicles and enhancers on the topical delivery of cyclosporin A. Int. J. Pharm. 311 (2006) 182-186
15. Alberti I., Kalia Y.N., Naik A., Bonny J., and Guy R.H. Effect of ethanol and isopropylmiristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int. J. Pharm. 219 (2001) 11-19
16. Schreier H., and Bouwstra J. Liposomes and niosomes as drug carriers: dermal and transdermal drug delivery. J. Cont. Release 30 (1994) 1-15
17. Hofland H.E., van der Geest R., Bodde H.E., Junginger H.E., and Bouwstra J.A. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm. Res. 11 (1994) 659-664
18. Cevc G., Schätzlein A., and Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta 1564 (2002) 21-30
19. Verma D.D., and Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporine A. J. Cont. Release 97 (2004) 55-66
20. Cevc G., and Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta 1663 (2004) 61-73
21. Verma D.D., Verma S., Blume G., and Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm. 258 (2003) 41-151
22. Song Y.-K., and Kim C.-K. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27 (2006) 271-280
23. Cevc G., and Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104 (1992) 226-232
24. van den Bergh B.A.I., Bouwstra J.A., Junginger H.E., and Wertz P.W. Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Cont. Release 62 (1999) 367-379
25. El Maghraby G.M.M., Williams A.C., and Barry B.W. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J. Pharm. Pharmacol. 51 (1999) 1123-1134
26. El Maghraby G.M.M., Williams A.C., and Barry B.W. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol. 53 (2001) 1069-1077
27. D.D. Verma, Invasomes-novel topical carriers for enhanced topical delivery: characterization and skin penetration properties, Marburg/Lahn 2002, Ph.D. Thesis.
28. Krishnaiah Y.S., Satyanarayana V., and Karthikeyan R.S. Penetration enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropylcellulose gels. Pharm. Dev. Technol. 7 (2002) 305-331
29. Kunta J.R., Goskonda V.R., Brotherton H.O., Khan M.A., and Reddy I.K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 86 (1997) 1369-1373
30. Puglia C., Bonina F., Trapani G., Franco M., and Ricci M. Evaluation of in vitro percuatneous absorption of lorazepam and clonazepam from hydroalcoholic gel formulations. Int. J. Pharm. 228 (2001) 79-87
31. Vaddi H.K., Ho P.C., Chan Y.W., and Chan S.Y. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum cornrum changes. J. Cont. Release 81 (2002) 121-133
32. El-Kattan A.F., Asbill C.S., Kim N., and Michniak B.B. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 215 (2001) 229-240
33. Bhatia K.S., and Singh J. Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultrastructure of human epidermis. Int. J. Pharm. 180 (1999) 235-250
34. Kobayashi D., Matsuzawa T., Sugibayashi Y., Morimoto, and Kimura M. Analysis of the combined effect of l-menthol and ethanol as skin penetration enhancers based on a two-layer skin model. Pharm. Res. 11 (1994) 96-103
35. Tata S., Weiner N., and Flynn G. Relative influence of ethanol and propylenglycol cosolvents on deposition of minoxidil into the skin. J. Pharm. Sci. 83 (1994) 1508-1510
36. Srinivasan V., Su M.H., Higuchi W.I., and Behl C.R. Iontophoresis of polypeptides: effect of ethanol pre-treatment of human skin. J. Pharm. Sci. 79 (1990) 558-591
37. Ota Y., Hamada A., Nakano M., and Saito H. Evaluation of percutaneous absorption of midazolam by terpenes. Drug Metab. Pharmacokin. 18 (2003) 261-266
38. Paolino D., Giuseppe L., Mardente D., Alhaique F., and Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Cont. Release 106 (2005) 99-110
39. Touitou E., Dayan N., Bergelson L., Godin B., and Eliaz M. Ethosomes-novel vesicular, carriers for enhanced delivery: characterization and skin penetration properties. J. Cont. Release 65 (2000) 403-418
40. Verma D.D., Verma S., McElwee K.J., Freyschmidt-Paul P., and Fahr A. Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. Eur. J. Dermatol. 14 (2004) 332-338
41. Parikh D.K., and Ghosh T.K. Feasibility of transdermal delivery of fluoxetine. AAPS Pharm. Sci. Tech. 6 (2005) E144-E149
42. Jeffes E.W., McCullough J.L., Weinstein G.D., Kaplan R., Glazer S.D., and Taylor J.R. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J. Am. Acad. Dermatol. 45 (2001) 96-104
43. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J. Photochem. Photobiol. B 29 (1995) 53-57